Pure Global

Characterization and Modulation of Traumatic Memories in PTSD Patients Using TMS - Trial NCT06372639

Access comprehensive clinical trial information for NCT06372639 through Pure Global AI's free database. This phase not specified trial is sponsored by Tel Aviv University and is currently Recruiting. The study focuses on Post Traumatic Stress Disorder. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06372639
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06372639
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Characterization and Modulation of Traumatic Memories in PTSD Patients Using TMS

Study Focus

Trans-Cranial Magnetic Stimulation

Interventional

device

Sponsor & Location

Tel Aviv University

Tel Aviv, Israel

Timeline & Enrollment

N/A

Feb 23, 2022

Nov 24, 2024

80 participants

Primary Outcome

CAPS-5 score,Neurological measures of functional connectivity,Intrusive memories

Summary

Characterization and modulation of traumatic memories in PTSD patients using TMS.

ICD-10 Classifications

Post-traumatic stress disorder
Traumatic shock
Personal history of psychological trauma, not elsewhere classified
State of emotional shock and stress, unspecified
Neurotic, stress-related and somatoform disorders

Data Source

ClinicalTrials.gov

NCT06372639

Device Trial